All Outputs (12)

Modulating the Biological Function of Protein by Tailoring the Adsorption Orientation on Nanoparticles (2020)
Other
Jain, A., Trindade, G., Hicks, J. M., Potts, J. C., Rahman, R., Hague, R., …Rawson, F. Modulating the Biological Function of Protein by Tailoring the Adsorption Orientation on Nanoparticles

Protein orientation in nanoparticle-protein conjugates plays a crucial role in binding to cell receptors and ultimately, defines their targeting efficiency. Therefore, understanding fundamental aspects of the role of protein orientation upon adsorpti... Read More about Modulating the Biological Function of Protein by Tailoring the Adsorption Orientation on Nanoparticles.

Persistent intestinal abnormalities and symptoms in cystic fibrosis: The underpinning mechanisms impacting gut health and motility. Protocol for a systematic review. (2020)
Other
Marsh, R. J., Ng, C., Major, G., Rivett, D. W., Smyth, A. R., & Gast, C. V. D. Persistent intestinal abnormalities and symptoms in cystic fibrosis: The underpinning mechanisms impacting gut health and motility. Protocol for a systematic review

Background Patients with cystic fibrosis (CF) are characterised by abnormalities of the intestinal tract relating to gut motility and physiological issues, with daily symptoms of disease including abdominal pain, flatulence, bloating, and constipatio... Read More about Persistent intestinal abnormalities and symptoms in cystic fibrosis: The underpinning mechanisms impacting gut health and motility. Protocol for a systematic review..

An ex vivocystic fibrosis model recapitulates key clinical aspects of chronic Staphylococcus aureus infection (2019)
Other
Sweeney, E., Hassan, M. M., Harrington, N. E., Smyth, A. R., Hurley, M. N., Tormo-Mas, M. Á., & Harrison, F. (2019). An ex vivocystic fibrosis model recapitulates key clinical aspects of chronic Staphylococcus aureus infection

Staphylococcus aureus is one of the most prevalent organisms isolated from the airways of people with cystic fibrosis (CF), predominantly early in life. Yet its role in the pathology of lung disease is poorly understood. Clinical studies are limited... Read More about An ex vivocystic fibrosis model recapitulates key clinical aspects of chronic Staphylococcus aureus infection.

Working with the patient and clinical community to deliver clinical research in cystic fibrosis: James Lind CF Phase II (2018)
Other
Smith, S., Rowbotham, N. J., & Smyth, A. R. (2018). Working with the patient and clinical community to deliver clinical research in cystic fibrosis: James Lind CF Phase II. London

This is a protocol which sets out the aims, objectives and commitments of the second phase of the James Lind Alliance Priority Setting Partnership in Cystic Fibrosis and the basic roles and responsibilities of the partners therein. The James Lind... Read More about Working with the patient and clinical community to deliver clinical research in cystic fibrosis: James Lind CF Phase II.

Using digital technology for adherence, home monitoring and self-management in cystic fibrosis: Protocol for a state of the art review
Other
Calthorpe, R., Smyth, A., Smith, S., & Gathercole, K. Using digital technology for adherence, home monitoring and self-management in cystic fibrosis: Protocol for a state of the art review

Protocol – review article: Where Next For Translational Research In Bronchopulmonary Dysplasia - Insights From Cellular Pathology
Other
Calthorpe, R., Poulter, C., Morty, R., Hilgendorff, A., Sucre, J., Smyth, A., & Jenkins, G. (2020). Protocol – review article: Where Next For Translational Research In Bronchopulmonary Dysplasia - Insights From Cellular Pathology

Exploring the challenges of accessing medications for patients with cystic fibrosis
Other
Herbert, S., Rowbotham, N., Smith, S., & Smyth, A. Exploring the challenges of accessing medications for patients with cystic fibrosis

Cystic Fibrosis James Lind Alliance Priority Setting Partnership PROTOCOL [5 February 2016]
Other
Smyth, A. R., Rowbotham, N. J., McPhee, M., & Smith, S. Cystic Fibrosis James Lind Alliance Priority Setting Partnership PROTOCOL [5 February 2016]

The purpose of this protocol is to set out the aims, objectives and commitments of the Cystic Fibrosis Priority Setting Partnership (PSP) and the basic roles and responsibilities of the partners therein.

Cystic Fibrosis James Lind Alliance Priority Setting Partnership PROTOCOL [updated 13 July 2016]
Other
Smyth, A. R., Rowbotham, N. J., McPhee, M., & Smith, S. Cystic Fibrosis James Lind Alliance Priority Setting Partnership PROTOCOL [updated 13 July 2016]

The purpose of this protocol is to set out the aims, objectives and commitments of the Cystic Fibrosis Priority Setting Partnership (PSP) and the basic roles and responsibilities of the partners therein.

Research Protocol - Effect of anti-staphylococcal antibiotic prophylaxis upon isolation and colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and their resistant variants in cystic fibrosis
Other
Hurley, M., Smyth, A. R., Fogarty, A. W., McKeever, T. M., Rosenfeld, M., & Goss, C. (2016). Research Protocol - Effect of anti-staphylococcal antibiotic prophylaxis upon isolation and colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and their resistant variants in cystic fibrosis

A systematic review to identify how the current clinical trials landscape reflects the James Lind Alliance top 10 research priorities for cystic fibrosis
Other
Kalaitzis, I., Rowbotham, N. J., Smith, S., & Smyth, A. A systematic review to identify how the current clinical trials landscape reflects the James Lind Alliance top 10 research priorities for cystic fibrosis

This is a protocol to describe the methodology for a systematic review of clinical trials registries to identify intervention trials in the treatment of CF and map them to priorities for CF research.

Final Protocol and Statistical Analysis Plan for the SNAP Trial - a randomised, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy
Other
Coleman, T., Cooper, S., Thornton, J., Britton, J., Lewis, S., Watts, K., …Grainge, M. J. Final Protocol and Statistical Analysis Plan for the SNAP Trial - a randomised, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy

This NIHR HTA-funded smoking, nicotine and pregnancy (SNAP) trial investigated whether or not nicotine replacement therapy (NRT) is effective, cost-effective and safe when used for smoking cessation by pregnant women. We randomised 1050 women who wer... Read More about Final Protocol and Statistical Analysis Plan for the SNAP Trial - a randomised, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy.